Back | Next |
home / stock / rdhl / rdhl message board
Subject | By | Source | When |
---|---|---|---|
The gaining up | midastouch017 | investorshub | 04/24/2023 3:25:43 AM |
The gaining up | Big Wheel | investorshub | 04/24/2023 2:11:31 AM |
MomentumIts trading | midastouch017 | investorshub | 04/24/2023 12:08:09 AM |
$RDHL Lets go go go go... Up up and away we go. | carusso | investorshub | 04/23/2023 10:27:43 PM |
$RDHL we got news | seve333 | investorshub | 04/23/2023 9:11:50 AM |
MomentumIts gaining | midastouch017 | investorshub | 04/23/2023 7:24:45 AM |
$RDHL short data if anyone is interested | seve333 | investorshub | 04/22/2023 6:47:39 PM |
bears are running | midastouch017 | investorshub | 04/22/2023 12:33:08 PM |
$RDHL Price gaining last trade up | midastouch017 | investorshub | 04/22/2023 5:59:12 AM |
$RDHL MomentumIts gaining | midastouch017 | investorshub | 04/21/2023 10:46:59 PM |
Price now | midastouch017 | investorshub | 04/21/2023 12:14:09 PM |
$RDHL The gaining | midastouch017 | investorshub | 04/21/2023 10:40:54 AM |
$RDHL Price now last up | carusso | investorshub | 04/21/2023 10:04:45 AM |
$RDHL what do you make of this data? | midastouch017 | investorshub | 04/21/2023 8:19:33 AM |
bulls and bears | midastouch017 | investorshub | 04/20/2023 10:24:45 PM |
MomentumIts gaining up | midastouch017 | investorshub | 04/20/2023 3:20:03 PM |
$RDHL good read | midastouch017 | investorshub | 04/20/2023 1:11:17 PM |
Price gaining | carusso | investorshub | 04/20/2023 9:55:14 AM |
is it bear time? Or do we go bull? | midastouch017 | investorshub | 04/20/2023 9:32:45 AM |
$RDHL must see | midastouch017 | investorshub | 04/20/2023 8:24:10 AM |
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 PR Newswire The new Chinese patent for opaganib as a therapy for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) is valid through 2035 and adds to opaganib's ...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study PR Newswire First patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat) 1 for early COVID-19 outpatient treatment, funded through non-...
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights PR Newswire RedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a disciplined cost-base ...